Global Adenovirus Vector Vaccine Market Growth (Status and Outlook) 2022-2028
- LP 4832977
- 89 Pages
- February 2022
- Pharmaceuticals
The United States Adenovirus Vector Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Adenovirus Vector Vaccine market, reaching US$ million by the year 2028. As for the Europe Adenovirus Vector Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Adenovirus Vector Vaccine players cover Johnson & Johnson, CanSino Biologics, Greffex, and BravoBio, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Adenovirus Vector Vaccine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Being Developed
Preclinical
Clinical I
Clinical II
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
CanSino Biologics
Greffex
BravoBio
Altimmune
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adenovirus Vector Vaccine Market Size 2017-2028
2.1.2 Adenovirus Vector Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Adenovirus Vector Vaccine Segment by Type
2.2.1 Being Developed
2.2.2 Preclinical
2.2.3 Clinical I
2.2.4 Clinical II
2.3 Adenovirus Vector Vaccine Market Size by Type
2.3.1 Adenovirus Vector Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Adenovirus Vector Vaccine Market Size Market Share by Type (2017-2022)
2.4 Adenovirus Vector Vaccine Segment by Application
2.4.1 Pharmaceutical And Biotechnology Companies
2.4.2 Hospital
2.4.3 Academic And Research Organizations
2.4.4 Other
2.5 Adenovirus Vector Vaccine Market Size by Application
2.5.1 Adenovirus Vector Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Adenovirus Vector Vaccine Market Size Market Share by Application (2017-2022)
3 Adenovirus Vector Vaccine Market Size by Player
3.1 Adenovirus Vector Vaccine Market Size Market Share by Players
3.1.1 Global Adenovirus Vector Vaccine Revenue by Players (2020-2022)
3.1.2 Global Adenovirus Vector Vaccine Revenue Market Share by Players (2020-2022)
3.2 Global Adenovirus Vector Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Adenovirus Vector Vaccine by Regions
4.1 Adenovirus Vector Vaccine Market Size by Regions (2017-2022)
4.2 Americas Adenovirus Vector Vaccine Market Size Growth (2017-2022)
4.3 APAC Adenovirus Vector Vaccine Market Size Growth (2017-2022)
4.4 Europe Adenovirus Vector Vaccine Market Size Growth (2017-2022)
4.5 Middle East & Africa Adenovirus Vector Vaccine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Adenovirus Vector Vaccine Market Size by Country (2017-2022)
5.2 Americas Adenovirus Vector Vaccine Market Size by Type (2017-2022)
5.3 Americas Adenovirus Vector Vaccine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adenovirus Vector Vaccine Market Size by Region (2017-2022)
6.2 APAC Adenovirus Vector Vaccine Market Size by Type (2017-2022)
6.3 APAC Adenovirus Vector Vaccine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Adenovirus Vector Vaccine by Country (2017-2022)
7.2 Europe Adenovirus Vector Vaccine Market Size by Type (2017-2022)
7.3 Europe Adenovirus Vector Vaccine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adenovirus Vector Vaccine by Region (2017-2022)
8.2 Middle East & Africa Adenovirus Vector Vaccine Market Size by Type (2017-2022)
8.3 Middle East & Africa Adenovirus Vector Vaccine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Adenovirus Vector Vaccine Market Forecast
10.1 Global Adenovirus Vector Vaccine Forecast by Regions (2023-2028)
10.1.1 Global Adenovirus Vector Vaccine Forecast by Regions (2023-2028)
10.1.2 Americas Adenovirus Vector Vaccine Forecast
10.1.3 APAC Adenovirus Vector Vaccine Forecast
10.1.4 Europe Adenovirus Vector Vaccine Forecast
10.1.5 Middle East & Africa Adenovirus Vector Vaccine Forecast
10.2 Americas Adenovirus Vector Vaccine Forecast by Country (2023-2028)
10.2.1 United States Adenovirus Vector Vaccine Market Forecast
10.2.2 Canada Adenovirus Vector Vaccine Market Forecast
10.2.3 Mexico Adenovirus Vector Vaccine Market Forecast
10.2.4 Brazil Adenovirus Vector Vaccine Market Forecast
10.3 APAC Adenovirus Vector Vaccine Forecast by Region (2023-2028)
10.3.1 China Adenovirus Vector Vaccine Market Forecast
10.3.2 Japan Adenovirus Vector Vaccine Market Forecast
10.3.3 Korea Adenovirus Vector Vaccine Market Forecast
10.3.4 Southeast Asia Adenovirus Vector Vaccine Market Forecast
10.3.5 India Adenovirus Vector Vaccine Market Forecast
10.3.6 Australia Adenovirus Vector Vaccine Market Forecast
10.4 Europe Adenovirus Vector Vaccine Forecast by Country (2023-2028)
10.4.1 Germany Adenovirus Vector Vaccine Market Forecast
10.4.2 France Adenovirus Vector Vaccine Market Forecast
10.4.3 UK Adenovirus Vector Vaccine Market Forecast
10.4.4 Italy Adenovirus Vector Vaccine Market Forecast
10.4.5 Russia Adenovirus Vector Vaccine Market Forecast
10.5 Middle East & Africa Adenovirus Vector Vaccine Forecast by Region (2023-2028)
10.5.1 Egypt Adenovirus Vector Vaccine Market Forecast
10.5.2 South Africa Adenovirus Vector Vaccine Market Forecast
10.5.3 Israel Adenovirus Vector Vaccine Market Forecast
10.5.4 Turkey Adenovirus Vector Vaccine Market Forecast
10.5.5 GCC Countries Adenovirus Vector Vaccine Market Forecast
10.6 Global Adenovirus Vector Vaccine Forecast by Type (2023-2028)
10.7 Global Adenovirus Vector Vaccine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Adenovirus Vector Vaccine Product Offered
11.1.3 Johnson & Johnson Adenovirus Vector Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 CanSino Biologics
11.2.1 CanSino Biologics Company Information
11.2.2 CanSino Biologics Adenovirus Vector Vaccine Product Offered
11.2.3 CanSino Biologics Adenovirus Vector Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 CanSino Biologics Main Business Overview
11.2.5 CanSino Biologics Latest Developments
11.3 Greffex
11.3.1 Greffex Company Information
11.3.2 Greffex Adenovirus Vector Vaccine Product Offered
11.3.3 Greffex Adenovirus Vector Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Greffex Main Business Overview
11.3.5 Greffex Latest Developments
11.4 BravoBio
11.4.1 BravoBio Company Information
11.4.2 BravoBio Adenovirus Vector Vaccine Product Offered
11.4.3 BravoBio Adenovirus Vector Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BravoBio Main Business Overview
11.4.5 BravoBio Latest Developments
11.5 Altimmune
11.5.1 Altimmune Company Information
11.5.2 Altimmune Adenovirus Vector Vaccine Product Offered
11.5.3 Altimmune Adenovirus Vector Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Altimmune Main Business Overview
11.5.5 Altimmune Latest Developments
12 Research Findings and Conclusion
Table 1. Adenovirus Vector Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Being Developed
Table 3. Major Players of Preclinical
Table 4. Major Players of Clinical I
Table 5. Major Players of Clinical II
Table 6. Adenovirus Vector Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Adenovirus Vector Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Adenovirus Vector Vaccine Market Size Market Share by Type (2017-2022)
Table 9. Adenovirus Vector Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Adenovirus Vector Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Adenovirus Vector Vaccine Market Size Market Share by Application (2017-2022)
Table 12. Global Adenovirus Vector Vaccine Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Adenovirus Vector Vaccine Revenue Market Share by Player (2020-2022)
Table 14. Adenovirus Vector Vaccine Key Players Head office and Products Offered
Table 15. Adenovirus Vector Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adenovirus Vector Vaccine Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Adenovirus Vector Vaccine Market Size Market Share by Regions (2017-2022)
Table 20. Americas Adenovirus Vector Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Adenovirus Vector Vaccine Market Size Market Share by Country (2017-2022)
Table 22. Americas Adenovirus Vector Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Adenovirus Vector Vaccine Market Size Market Share by Type (2017-2022)
Table 24. Americas Adenovirus Vector Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Adenovirus Vector Vaccine Market Size Market Share by Application (2017-2022)
Table 26. APAC Adenovirus Vector Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Adenovirus Vector Vaccine Market Size Market Share by Region (2017-2022)
Table 28. APAC Adenovirus Vector Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Adenovirus Vector Vaccine Market Size Market Share by Type (2017-2022)
Table 30. APAC Adenovirus Vector Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Adenovirus Vector Vaccine Market Size Market Share by Application (2017-2022)
Table 32. Europe Adenovirus Vector Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Adenovirus Vector Vaccine Market Size Market Share by Country (2017-2022)
Table 34. Europe Adenovirus Vector Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Adenovirus Vector Vaccine Market Size Market Share by Type (2017-2022)
Table 36. Europe Adenovirus Vector Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Adenovirus Vector Vaccine Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Adenovirus Vector Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Adenovirus Vector Vaccine Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Adenovirus Vector Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Adenovirus Vector Vaccine Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Adenovirus Vector Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Adenovirus Vector Vaccine Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Adenovirus Vector Vaccine
Table 45. Key Market Challenges & Risks of Adenovirus Vector Vaccine
Table 46. Key Industry Trends of Adenovirus Vector Vaccine
Table 47. Global Adenovirus Vector Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Adenovirus Vector Vaccine Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Adenovirus Vector Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Adenovirus Vector Vaccine Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Adenovirus Vector Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Adenovirus Vector Vaccine Market Size Market Share Forecast by Application (2023-2028)
Table 53. Johnson & Johnson Details, Company Type, Adenovirus Vector Vaccine Area Served and Its Competitors
Table 54. Johnson & Johnson Adenovirus Vector Vaccine Product Offered
Table 55. Johnson & Johnson Adenovirus Vector Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Johnson & Johnson Main Business
Table 57. Johnson & Johnson Latest Developments
Table 58. CanSino Biologics Details, Company Type, Adenovirus Vector Vaccine Area Served and Its Competitors
Table 59. CanSino Biologics Adenovirus Vector Vaccine Product Offered
Table 60. CanSino Biologics Main Business
Table 61. CanSino Biologics Adenovirus Vector Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. CanSino Biologics Latest Developments
Table 63. Greffex Details, Company Type, Adenovirus Vector Vaccine Area Served and Its Competitors
Table 64. Greffex Adenovirus Vector Vaccine Product Offered
Table 65. Greffex Main Business
Table 66. Greffex Adenovirus Vector Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Greffex Latest Developments
Table 68. BravoBio Details, Company Type, Adenovirus Vector Vaccine Area Served and Its Competitors
Table 69. BravoBio Adenovirus Vector Vaccine Product Offered
Table 70. BravoBio Main Business
Table 71. BravoBio Adenovirus Vector Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. BravoBio Latest Developments
Table 73. Altimmune Details, Company Type, Adenovirus Vector Vaccine Area Served and Its Competitors
Table 74. Altimmune Adenovirus Vector Vaccine Product Offered
Table 75. Altimmune Main Business
Table 76. Altimmune Adenovirus Vector Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Altimmune Latest Developments
List of Figures
Figure 1. Adenovirus Vector Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adenovirus Vector Vaccine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Adenovirus Vector Vaccine Market Size Market Share by Type in 2021
Figure 7. Adenovirus Vector Vaccine in Pharmaceutical And Biotechnology Companies
Figure 8. Global Adenovirus Vector Vaccine Market: Pharmaceutical And Biotechnology Companies (2017-2022) & ($ Millions)
Figure 9. Adenovirus Vector Vaccine in Hospital
Figure 10. Global Adenovirus Vector Vaccine Market: Hospital (2017-2022) & ($ Millions)
Figure 11. Adenovirus Vector Vaccine in Academic And Research Organizations
Figure 12. Global Adenovirus Vector Vaccine Market: Academic And Research Organizations (2017-2022) & ($ Millions)
Figure 13. Adenovirus Vector Vaccine in Other
Figure 14. Global Adenovirus Vector Vaccine Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Adenovirus Vector Vaccine Market Size Market Share by Application in 2021
Figure 16. Global Adenovirus Vector Vaccine Revenue Market Share by Player in 2021
Figure 17. Global Adenovirus Vector Vaccine Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Adenovirus Vector Vaccine Market Size 2017-2022 ($ Millions)
Figure 19. APAC Adenovirus Vector Vaccine Market Size 2017-2022 ($ Millions)
Figure 20. Europe Adenovirus Vector Vaccine Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Adenovirus Vector Vaccine Market Size 2017-2022 ($ Millions)
Figure 22. Americas Adenovirus Vector Vaccine Value Market Share by Country in 2021
Figure 23. Americas Adenovirus Vector Vaccine Consumption Market Share by Type in 2021
Figure 24. Americas Adenovirus Vector Vaccine Market Size Market Share by Application in 2021
Figure 25. United States Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Adenovirus Vector Vaccine Market Size Market Share by Region in 2021
Figure 30. APAC Adenovirus Vector Vaccine Market Size Market Share by Application in 2021
Figure 31. China Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Adenovirus Vector Vaccine Market Size Market Share by Country in 2021
Figure 38. Europe Adenovirus Vector Vaccine Market Size Market Share by Type in 2021
Figure 39. Europe Adenovirus Vector Vaccine Market Size Market Share by Application in 2021
Figure 40. Germany Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Adenovirus Vector Vaccine Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Adenovirus Vector Vaccine Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Adenovirus Vector Vaccine Market Size Market Share by Application in 2021
Figure 48. Egypt Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Adenovirus Vector Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 54. APAC Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 55. Europe Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 57. United States Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 58. Canada Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 61. China Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 62. Japan Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 63. Korea Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 65. India Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 66. Australia Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 67. Germany Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 68. France Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 69. UK Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 70. Italy Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 71. Russia Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 72. Spain Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 75. Israel Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Adenovirus Vector Vaccine Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
